Positive Predictive Value of Sustained Virologic Response 4 Weeks Posttreatment for Achieving Sustained Virologic Response 12 Weeks Posttreatment in Patients Receiving Glecaprevir/pibrentasvir in Phase 2 and 3 Clinical Trials
Journal of viral hepatitis（2021）
关键词
care cascade,concordance,direct-acting antivirals,hepatitis C virus,sustained virologic response
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要